Medplus Health Services Ltd Share Price Today - Medplus Health Services Ltd Stock Price Live NSE/BSE

Medplus Health Services Ltd

NSE: MEDPLUS BSE: 543427

₹874.70

(-0.77%)

Sun, 17 May 2026, 02:29 pm

MTF 5xInvest in Medplus Health Services Ltd with 5x Leverage Buy with MTF

Market Cap105.04B

PE Ratio50.70

Dividend0

Retail Trade

Drugstore Chains

24.5K

Medplus Health Services Share Price Live Chart

1 Day

(-0.77%)

No Result Found

Summary

Market Cap
11426.80
Net Profit
150.23
P/B
5.22
Sector P/E
76.84
P/E
60.47
EV/EBITDA
18.38
Debt/Equity (Industry)
0.52
Interest Cover (Industry)
0
ROCE (Industry)
0
RONW (Industry)
0
ROE
9.05
ROCE
10.36
Debt/Equity
0.64
EPS (TTM)
17.24
Dividend Yield
0
Book Value
153.68
Interest Cover
2.79

Analysis

No Result Found

Financials

Ratios

No Result Found

Shareholders	MAR 2026	DEC 2025	SEPT 2025	JUN 2025	MAR 2025
Promoters	40.22	40.29	40.29	40.32	40.34
FII	15.53	16.83	16.54	16.42	15.61
DII	27.82	26.57	26.52	26.04	26.19
Public	16.44	16.30	16.65	17.22	17.87
Government	0	0	0	0	0

Technical Analysis

RSI

MACD

50 DMA

200 DMA

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	-	-	-	-	-	-	-
Fibonacci	-	-	-	-	-	-	-
Camarilla	-	-	-	-	-	-	-

Pivots Level: Classic

Pivot Point

LTP: -

Moving Average

SMAEMA

Period

Value

10-EMA
-
20-EMA
-
30-EMA
-
50-EMA
-
100-EMA
-
200-EMA
-

Announcement Date	Purpose	Action
30 Jan 2026	board-meetings	Quarterly Results
31 Oct 2025	board-meetings	Quarterly Results
02 Aug 2025	agm
02 Aug 2024	agm
13 Nov 2023	egm
07 Aug 2023	agm
09 Sept 2022	agm

Peer Comparison

No Result Found

Medplus Health Services Ltd About

Medplus Health Services is primarily engaged in the business of provision of diagnostic services pathological services and laboratory testing services.

Industry

Trading

Founded

2006

Headquarters

CEO

GANGADI MADHUKAR REDDY

Employees

Contact

Website

http://www.medplusindia.com

cs@medplusindia.com; ir@medplusindia.com

Phone

91-040-6724 6724

Location

707 7th Floor 5-9-13 Saifabad, Taramandal Commercial Complex, Hyderabad, Telangana, 500004

Year	History
2012	The EBITDA of the company turned positive.
2017	Gangadi Investments Private Limited acquired 122,347 equity shares, 12,000,000 unlisted redeemable preference shares and 42,847,000 non-convertible debentures.
2019	PI Opportunities Fund - I invested, acquiring a 22.21% stake of the company, through purchase of 21,233 equity shares.
2021	The company was converted from a private limited company to a public limited company. The name of the company was changed to MedPlus Health Services Limited. A fresh certificate of incorporation was issued by the Registrar of Companies, Telangana at Hyderabad. Lavender Rose invested 6.56 billion, acquiring a 24.58% stake of the company. PI Opportunities Fund - I invested 222.10 million by subscribing to 160,147 Series C2 CCPS.
2023	Medplus Health Services Ltd. got approval from NCL regarding the Scheme of Amalgamation of MHS Pharmaceuticals Private Limited with MedPlus Health Services Limited.

Client Name	Deal Type	Order Side	QTY	Avg Price	Date
GRAVITON RESEARCH CAPITAL LLP	bulk	Buy	673825	836.74	03 Nov 2025
GRAVITON RESEARCH CAPITAL LLP	bulk	Sell	673497	837.39	03 Nov 2025
FRANKLIN TEMPLETON MF INDIA SMALLER COMPANIES FUND	bulk	Buy	777950	700	18 Nov 2024
FRANKLIN TEMPLETON MUTUAL FUND	block	Buy	1607867	700	18 Nov 2024
INVESCO MUTUAL FUND	block	Buy	3071429	700	18 Nov 2024
KOTAK MAHINDRA MUTUAL FUND	block	Buy	3071429	700	18 Nov 2024
PI OPPORTUNITIES FUND - I	block	Sell	6893583	700	18 Nov 2024
MORGAN STANLEY ASIA SINGAPORE PTE	block	Buy	142858	700	18 Nov 2024
SBI MUTUAL FUND	block	Sell	1000000	700	18 Nov 2024
FRANKLIN TEMPLETON MF FLEXI CAP FUND	bulk	Buy	829917	700	18 Nov 2024

Medplus Health Services Ltd News

MedPlus Subsidiary Drug License Suspensions Rise to 8 Stores

Optival Health Solutions, MedPlus subsidiary, received drug license suspensions for stores across Maharashtra, Telangana, Karnataka & Delhi, with combined potential revenue loss of Rs 7.25 lacs.

16 May 2026

companies

MedPlus Subsidiary Drug License Suspensions Rise to 7

Optival Health Solutions, MedPlus subsidiary, received drug license suspensions for stores across Maharashtra, Telangana, Karnataka & Delhi, with combined potential revenue loss of Rs 4.76 lacs.

14 May 2026

companies

MedPlus Subsidiary Gets Drug License Suspensions in 7 Stores

Optival Health Solutions, MedPlus subsidiary, received drug license suspensions for stores across Maharashtra, Telangana, Karnataka & Delhi, with combined potential revenue loss of Rs 4.76 lacs.

13 May 2026

companies

MedPlus Subsidiary Gets Drug License Suspensions in 6 Stores

Optival Health Solutions, MedPlus subsidiary, received drug license suspensions for stores across Maharashtra, Telangana, Karnataka & Delhi, with combined potential revenue loss of Rs 4.00 lacs.

12 May 2026

companies

MedPlus Subsidiary Gets Drug License Suspensions in 4 States

Optival Health Solutions, MedPlus subsidiary, received drug license suspensions for stores in Maharashtra, Telangana, Karnataka & Delhi, with combined potential revenue loss of Rs 1.29 lacs.

11 May 2026

companies

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800